Pancreatic Cancer Research

ResearcherLonghua Hospital Shanghai University of Traditional Chinese MedicineActive in the last 2 years

Changsheng Dong

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0001-8385-7904; OpenAlex author ID A5017055102, A5125622743.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Collaborators
4
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway. First author DOI 10.1002/fsn3.72468↗
  2. Current status and future prospects of immunotherapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.4103/jcrt.jcrt_1142_25↗
  3. Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E. Last author DOI 10.3389/fimmu.2025.1569088↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Junqian Zhang · 1 shared paper, 2025
  2. Xi Wu · 1 shared paper, 2026
  3. Yun Lou · 1 shared paper, 2026
  4. Wenguang Wu · 1 shared paper, 2026

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.